Skip to main content
Equibles
RSCF logo

RSCF · Reflect Scientific, Inc.

Track RSCF — free

Use RSCF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RSCF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.06 0.00 (-6.23%) At close · Nov 6
Rebalance outlook locked
Market Cap
$5.14M
Shares
85.66M
Volume · Nov 6 5320 Avg daily vol (3M) 93.72K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.06 Open$0.05 Day$0.05–0.06 52W close$0.04–0.06 Avg vol 30d69K Short int10K · 0.0% of shares · 1.0d Short vol1% DataJan 2020–Nov 2026 Filing10-Q · Nov 12

Latest documents

2024
Nov 12
Quarterly report 10-Q FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $514.02K ▼ 2.3% Net income $109.93K ▲ 27.4% Diluted EPS $0.00
Aug 13
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $590.07K ▲ 374.4% Net income $108.99K Diluted EPS $0.00
Mar 29
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $1.08M ▼ 47.1% Net loss $459.03K Diluted EPS -$0.01
2023
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.72M
Trailing 12 months
Net income (TTM)
−$29,419
Trailing 12 months
Revenue growth YoY
-2.3%
Year over year
Operating margin
-3.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.03M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
+18.8%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 25.6 · fear Equity put/call 0.59
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +15%
above
Price vs 50-day avg +3%
above
RSI (14) 49
neutral
MACD trend Negative
52-week position 69%
mid-range
Momentum
relative strength
Very Strong
1-month return +1%
trailing
6-month return +11%
trailing
YTD return +11%
this year
Relative strength +12%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Distributing
1 of 1 funds reported for Sep 30 · net -900 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.01% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 5-yr low, contrarian setup
Squeeze score 25
low risk · 0–100
Fundamentals
Fair
Revenue growth −47%
Y/Y
Gross margin 55%
contracting
Quant / Vol
risk profile
Very High
Volatility 127%
annualized · 1-yr
Max drawdown −52%
past year
ATR 10.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+15% Bullish
Price vs 50-day avg
+3% Bullish
RSI (14)
49 Neutral
MACD trend
Negative Bearish
52-week position
69% Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Distributing
1 of 1 funds reported for Sep 30 · net -900 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.01% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 5-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 69% Range high $0
vs 200-day avg +15% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RSCF
Reflect Scientific, Inc.
this stock
$5.14M +11.4% -47.1% — 0.0%
ISRG
Intuitive Surgical Inc
 $162.41B -20.1% +20.5% 56.8 2.1%
BDX
Becton Dickinson & Co
 $57.71B — +8.2% 93.8 3.3%
MDLN
Medline Inc.
 $52.30B -5.6% +11.5% — 3.1%
ALC
Alcon Inc
 $36.23B -4.9% +10.5% — 4.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1
% held
0.0%
Reported
1 of 1
Top holder
RMG Wealth Management LLC
Held Float
View
Short & Settlement
Short Interest
Shares short
10.0K
Days to cover
1.0d
Change
0 sh
View
Short Volume
Short vol %
1%
As of
Nov 5, 2026
Short Total
View
Fails to Deliver
FTD shares
73.0K
Value
$2.9K
As of
Jul 2, 2026
View
Off-Exchange
Off-exchange %
97.1%
Week of
Sep 28, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.1M
Net income (FY)
$-459.0K
EPS diluted
$-0.01
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 12, 2024
This year
0
View
Proposed Sales
Value
$4.0K
Shares
100.0K
Filed
May 16, 2024
View

Performance

5D 20D 120D MTD YTD
RSCF -5.0% +1.3% +11.4% -5.0% +11.4%
SPY -2.7% -5.6% -0.5% -2.7% +7.8%
vs SPY -2.3% +6.8% +11.9% -2.3% +3.6%
Key facts CIK 1103090 CUSIP 75866F101 13F (30d) 1 filings 1 filers Visit website